miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
出版年份 2018 全文链接
标题
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
作者
关键词
-
出版物
Nature Communications
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-03-08
DOI
10.1038/s41467-018-03348-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recurrent ovarian cancer
- (2016) E. Pujade-Lauraine et al. ANNALS OF ONCOLOGY
- FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling
- (2016) Xuguang Yang et al. CANCER RESEARCH
- Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
- (2016) Philippe Gascard et al. GENES & DEVELOPMENT
- Suppressive activity of human regulatory T cells is maintained in the presence of TNF
- (2016) Bruno Zaragoza et al. NATURE MEDICINE
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
- (2016) S Lefort et al. ONCOGENE
- Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
- (2016) Megan K. Ruhland et al. Nature Communications
- Regulation of miR-200c/141 expression by intergenic DNA-looping and transcriptional read-through
- (2016) Luciana Batista et al. Nature Communications
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival
- (2016) Sara Corvigno et al. Oncotarget
- Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer
- (2015) Keith L. Knutson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas
- (2015) Tina Gruosso et al. Nature Communications
- Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
- (2015) Kim Moran-Jones et al. Oncotarget
- Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset
- (2015) Gurcan Gunaydin et al. OncoImmunology
- Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer
- (2015) Isaiah G. Schauer et al. NEOPLASIA
- MicroRNA-200 Is Induced by Thioredoxin-interacting Protein and Regulates Zeb1 Protein Signaling and Beta Cell Apoptosis
- (2014) Stephen R. Filios et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
- (2014) Margaret Gil et al. JOURNAL OF IMMUNOLOGY
- Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
- (2014) Gottfried E. Konecny et al. JNCI-Journal of the National Cancer Institute
- The Prognostic Value of CXCR4 in Ovarian Cancer: A Meta-Analysis
- (2014) Cheng-Fei Liu et al. PLoS One
- The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance
- (2014) D. T. Fearon Cancer Immunology Research
- Cancer Associated Fibroblasts express pro-inflammatory factors in human breast and ovarian tumors
- (2013) Neta Erez et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition
- (2013) Benoît Thibault et al. CANCER AND METASTASIS REVIEWS
- Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and “fibroblast addiction” are new therapeutic targets for drug discovery
- (2013) Michael P. Lisanti et al. CELL CYCLE
- A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer
- (2013) Dong-Joo Cheon et al. CLINICAL CANCER RESEARCH
- miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease
- (2013) Zhen Huang et al. GUT
- Ovarian cancer emerging subtypes: Role of oxidative stress and fibrosis in tumour development and response to treatment
- (2013) L. Batista et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
- (2012) A Popple et al. BRITISH JOURNAL OF CANCER
- Oxidative Stress Mediated-Alterations of the MicroRNA Expression Profile in Mouse Hippocampal Neurons
- (2012) Shunjiang Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts
- (2012) Song Yi Ko et al. JOURNAL OF CLINICAL INVESTIGATION
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
- (2012) M T M van Jaarsveld et al. ONCOGENE
- Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
- (2012) Stefan Bentink et al. PLoS One
- CXCL12 expression by healthy and malignant ovarian epithelial cells
- (2011) Véronique Machelon et al. BMC CANCER
- Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion
- (2011) Yuan Zhang et al. CANCER LETTERS
- A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
- (2011) H. Kulbe et al. CANCER RESEARCH
- CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
- (2011) E. Righi et al. CANCER RESEARCH
- miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition
- (2011) A Magenta et al. CELL DEATH AND DIFFERENTIATION
- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling
- (2011) Wei Tan et al. NATURE
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE
- (2011) Peng Qiu et al. NATURE BIOTECHNOLOGY
- miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
- (2011) Bogdan Mateescu et al. NATURE MEDICINE
- Oxidative stress promotes myofibroblast differentiation and tumour spreading
- (2010) Aurore Toullec et al. EMBO Molecular Medicine
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses inBRCACarrier Ovarian Cancer Correlating With Platinum-Free Interval
- (2010) Peter C. Fong et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-
- (2010) M. Kraman et al. SCIENCE
- Functional diversity of SDF-1 splicing variants
- (2010) Miroslaw Janowski Cell Adhesion & Migration
- miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion
- (2009) Hongping Xia et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
- (2009) Masayuki Shimoda et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started